Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Home Interventions and Light Therapy for the Treatment of Vitiligo
2014-003473-42Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Mar 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of mometasone in Vitiligo (2 arms), sponsored by University of Nottingham. Primary endpoint: Participant-reported treatment success for a target lesion. Started Mar 2015; status: completed.
02
Drugs
mometasone
03
Conditions
Vitiligo
Beyond the preview
Go deeper on 2014-003473-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003473-42.